Award recordCONTRACT

NANOSPHERE, LLC

PIID VA25917J0025· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2017· $70,379 net obligations· UEI DNQ4H6RCTMJ5· IL

Description

DE-OBLIGATING FUNDS DENVER VERIGENE TEST KIT FUNDING

Base award description: IGF::OT::IGF DENVER VERIGENE TEST KIT FUNDING

First action · last action
2016-10-03 · 2021-11-15
Transactions
2
First transaction's obligation
$80,000
Base + all options value (sum of deltas)
$70,379
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25914A0171
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$80,000$0Base award · 2016-10-03 · this action $80,000 · running total $80,000Modification P00001 · 2021-11-15 · this action -$9,621 · running total $70,379
  • Base2016-10-03+$80,000= $80,000
  • Mod P000012021-11-15-$9,621= $70,379
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-03+$80,000$80,000IGF::OT::IGF DENVER VERIGENE TEST KIT FUNDING
Mod P00001· FUNDING ONLY ACTION2021-11-15−$9,621$70,379DE-OBLIGATING FUNDS DENVER VERIGENE TEST KIT FUNDING

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DNQ4H6RCTMJ5)

AwardOffice · PSC / listingNet obligationsFY
36C26220N0113262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$74,577FY2020
36C26219N0189262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$48,385FY2019
36C25919N0012NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$80,000FY2019
36C25918N1818NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$20,599FY2018
36C26018P0854260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$47,945FY2018
36C24418P0693244-NETWORK CONTRACT OFFICE 4 (36C244) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$80,066FY2018

Other recipients under 6550 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926N0457BECTON, DICKINSON AND COMPANYNETWORK CONTRACT OFFICE 19 (36C259)$147,256FY2026
36C25926N0353QIAGEN, LLCNETWORK CONTRACT OFFICE 19 (36C259)$88,310FY2026
36C25926N0292FISHER SCIENTIFIC COMPANY L.L.C.NETWORK CONTRACT OFFICE 19 (36C259)$165,000FY2026
36C25926N0280ALBA BIOSCIENCE, INC.NETWORK CONTRACT OFFICE 19 (36C259)$64,078FY2026
36C25926N0316POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLCNETWORK CONTRACT OFFICE 19 (36C259)$50,343FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25917J0025_3600_VA25914A0171_3600 · retrieved 2026-09-26.